Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor After Pediatric Liver Transplantation

PLoS ONE - United States
doi 10.1371/journal.pone.0109464
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity After Renal Transplantation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients

Oncotarget
Oncology
2017English

The Impact of APOL1, CAV1, and ABCB1 Gene Variants on Outcomes in Kidney Transplantation: Donor and Recipient Effects

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2013English

Survival After Pediatric Liver Transplantation

Archives of Surgery
2005English

Laparoscopic Living Donor Hepatectomy for Pediatric Liver Transplantation

HPB
HepatologyGastroenterology
2017English

Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation

European Journal of Pediatric Surgery
Child HealthSurgeryPediatricsPerinatology
2012English

Pre Transplant Serum Magnesium Level Predicts Outcome After Pediatric Living Donor Liver Transplantation

Annals of Transplantation
MedicineTransplantation
2012English

Frailty After Liver Transplantation - The Strong Survive but May Not Prosper

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Splenectomy Is Not Indicated in Living Donor Liver Transplantation

Liver Transplantation
HepatologyTransplantationSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy